{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:45:31Z","timestamp":1781649931163,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.atherosclerosis.2016.12.022","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T03:05:55Z","timestamp":1482548755000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Uremia modulates the phenotype of aortic smooth muscle cells"],"prefix":"10.1016","volume":"257","author":[{"given":"Marie","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Aarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Albinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Hartvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Turczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars B.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja Xenia","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol. Dial. Transpl."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11255-013-0407-1","article-title":"The risk of atherosclerosis in patients with chronic kidney disease","volume":"45","author":"Olechnowicz-Tietz","year":"2013","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000346710","article-title":"Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study","volume":"37","author":"Schneider","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2016.12.022_bib6","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9237","key":"10.1016\/j.atherosclerosis.2016.12.022_bib7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.12.022_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2016.12.022_bib9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9887","key":"10.1016\/j.atherosclerosis.2016.12.022_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"issue":"7347","key":"10.1016\/j.atherosclerosis.2016.12.022_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.12.022_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","article-title":"Role of smooth muscle cells in the initiation and early progression of atherosclerosis","volume":"28","author":"Doran","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.12.022_bib13","first-page":"3","article-title":"Myocardin in biology and disease","volume":"29","author":"Miano","year":"2015","journal-title":"J.\u00a0Biomed. Res."},{"key":"10.1016\/j.atherosclerosis.2016.12.022_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.abb.2013.12.015","article-title":"Myocardin and smooth muscle differentiation","volume":"543","author":"Zheng","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.12.022_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.108.166066","article-title":"Myocardin is sufficient for a smooth muscle-like contractile phenotype","volume":"28","author":"Long","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2016.12.022_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cvr\/cvs094","article-title":"Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation","volume":"95","author":"Allahverdian","year":"2012","journal-title":"Cardiovasc Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.12.022_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/ATVBAHA.114.304029","article-title":"Cholesterol loading reprograms the microRNA-143\/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype","volume":"35","author":"Vengrenyuk","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2016.12.022_bib20","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1097\/01.ASN.0000088024.72216.2E","article-title":"Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice","volume":"14","author":"Bro","year":"2003","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.12.022_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cvr\/cvt049","article-title":"Osteopontin deficiency dampens the pro-atherogenic effect of uraemia","volume":"98","author":"Pedersen","year":"2013","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.12.022_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","article-title":"Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice","volume":"16","author":"Massy","year":"2005","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.12.022_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.ATV.0000201060.47945.cb","article-title":"Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Bro","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.atherosclerosis.2008.04.041","article-title":"Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice","volume":"202","author":"Pedersen","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.12.022_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/embor.2010.172","article-title":"miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation","volume":"12","author":"Sun","year":"2011","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/01.ASN.0000128371.33195.7B","article-title":"Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice","volume":"15","author":"Bro","year":"2004","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.12.022_bib27","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.HYP.29.3.770","article-title":"Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?","volume":"29","author":"Amann","year":"1997","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2016.12.022_bib28","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.111.226670","article-title":"Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation","volume":"31","author":"Davis-Dusenbery","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2016.12.022_bib29","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/ATVBAHA.112.301000","article-title":"Myocardin regulates vascular response to injury through miR-24\/-29a and platelet-derived growth factor receptor-beta","volume":"33","author":"Talasila","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.12.022_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/mmr.2013.1538","article-title":"MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-kappaB expression","volume":"8","author":"Dong","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2016.12.022_bib31","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/mmr.2014.3107","article-title":"MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway","volume":"11","author":"Cao","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2016.12.022_bib32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","article-title":"MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation","volume":"100","author":"Ji","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.12.022_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.12.022_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00005344-200405000-00013","article-title":"L-carnitine ameliorates oxidative damage due to chronic renal failure in rats","volume":"43","author":"Sener","year":"2004","journal-title":"J.\u00a0Cardiovasc Pharmacol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2016.12.022_bib35","doi-asserted-by":"crossref","first-page":"R1426","DOI":"10.1152\/ajpregu.00696.2011","article-title":"Vascular function in rats with adenine-induced chronic renal failure","volume":"302","author":"Nguy","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.12.022_bib36","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajh.2008.24","article-title":"Effect of exercise training on aortic tone in chronic renal insufficiency","volume":"21","author":"Shelkovnikov","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2007121312","article-title":"CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas","volume":"20","author":"Kokubo","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2016.12.022_bib38","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/ki.2010.353","article-title":"Chronic kidney disease aggravates arteriovenous fistula damage in rats","volume":"78","author":"Langer","year":"2010","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.12.022_bib39","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1600-6143.2012.04001.x","article-title":"Local medial microenvironment directs phenotypic modulation of smooth muscle cells after experimental renal transplantation","volume":"12","author":"Boersema","year":"2012","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.atherosclerosis.2016.12.022_bib40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/4337","article-title":"Chronic kidney disease alters vascular smooth muscle cell phenotype","volume":"20","author":"Monroy","year":"2015","journal-title":"Front. Biosci. (Landmark Ed."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501631543X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501631543X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T22:03:03Z","timestamp":1568671383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501631543X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"alternative-id":["S002191501631543X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.12.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uremia modulates the phenotype of aortic smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}